<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/285l–3" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/285l–3/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/285l–3/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_285l_3"><akn:num>285l–3</akn:num><akn:heading>Interagency Coordinating Committee on the Validation of Alternative Methods</akn:heading><akn:content><akn:p>§ 285l–3. Interagency Coordinating Committee on the Validation of Alternative Methods(a) In generalWith respect to the interagency coordinating committee that is known as the Interagency Coordinating Committee on the Validation of Alternative Methods (referred to in sections 285l–2 to 285l–5 of this title as “ICCVAM”) and that was established by the Director of the National Institute of Environmental Health Sciences for purposes of section 285l–1(b) of this title, the Director of the Institute shall designate such committee as a permanent interagency coordinating committee of the Institute under the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Sections 285l–2 to 285l–5 of this title may not be construed as affecting the authorities of such Director regarding ICCVAM that were in effect on the day before December 19, 2000, except to the extent inconsistent with sections 285l–2 to 285l–5 of this title.


(b) PurposesThe purposes of the ICCVAM shall be to—(1) increase the efficiency and effectiveness of Federal agency test method review;

(2) eliminate unnecessary duplicative efforts and share experiences between Federal regulatory agencies;

(3) optimize utilization of scientific expertise outside the Federal Government;

(4) ensure that new and revised test methods are validated to meet the needs of Federal agencies; and

(5) reduce, refine, or replace the use of animals in testing, where feasible.


(c) CompositionThe ICCVAM shall be composed of the heads of the following Federal agencies (or their designees):(1) Agency for Toxic Substances and Disease Registry.

(2) Consumer Product Safety Commission.

(3) Department of Agriculture.

(4) Department of Defense.

(5) Department of Energy.

(6) Department of the Interior.

(7) Department of Transportation.

(8) Environmental Protection Agency.

(9) Food and Drug Administration.

(10) National Institute for Occupational Safety and Health.

(11) National Institut</akn:p></akn:content><akn:subsection eId="subsec_285l_3_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general With respect to the interagency coordinating committee that is known as the Interagency Coordinating Committee on the Validation of Alternative Methods (referred to in sections 285l–2 to 285l–5 of this title as “ICCVAM”) and that was established by the Director of the National Institute of Environmental Health Sciences for purposes of section 285l–1(b) of this title, the Director of the Institute shall designate such committee as a permanent interagency coordinating committee of the Institute under the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Sections 285l–2 to 285l–5 of this title may not be construed as affecting the authorities of such Director regarding ICCVAM that were in effect on the day before December 19, 2000, except to the extent inconsistent with sections 285l–2 to 285l–5 of this title.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285l_3_b"><akn:num>(b)</akn:num><akn:heading>Purposes</akn:heading><akn:content><akn:p>(b) Purposes The purposes of the ICCVAM shall be to—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285l_3_c"><akn:num>(c)</akn:num><akn:heading>Composition</akn:heading><akn:content><akn:p>(c) Composition The ICCVAM shall be composed of the heads of the following Federal agencies (or their designees):</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285l_3_d"><akn:num>(d)</akn:num><akn:heading>Scientific Advisory Committee</akn:heading><akn:content><akn:p>(d) Scientific Advisory Committee</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285l_3_e"><akn:num>(e)</akn:num><akn:heading>Duties</akn:heading><akn:content><akn:p>(e) Duties The ICCVAM shall, consistent with the purposes described in subsection (b), carry out the following functions:</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>